STAT+: Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea
Caspian Therapeutics, is launching with $50 million in financing to develop menin inhibitors for diabetes and other cardiometabolic diseases.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.